Wittekoek M E, Pimstone S N, Reymer P W, Feuth L, Botma G J, Defesche J C, Prins M, Hayden M R, Kastelein J J
Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, The Netherlands.
Circulation. 1998 Mar 3;97(8):729-35. doi: 10.1161/01.cir.97.8.729.
Recently, a mutation in the lipoprotein lipase (LPL) gene (N291S) has been reported in 2% to 5% of individuals in western populations and is associated with increased triglyceride (TG) and reduced HDL cholesterol (HDLC) concentrations.
Here we report a significant alteration in biochemical and clinical phenotype in subjects with familial hypercholesterolemia (FH) who are heterozygous for this N291S LPL mutation. Sixty-four FH heterozygotes carrying the N291S mutation had significantly a higher TG level (P=.004), a higher ratio of total cholesterol to HDLC (P<.001), and lower HDLC concentrations (P=.002) compared with 175 FH heterozygotes without this LPL mutation. Moreover, the N291S mutation conferred a significantly greater risk for developing cardiovascular disease in FH heterozygotes compared with FH heterozygotes without this LPL mutation (odds ratio, 3.875; P=.006).
These data provide evidence that a common LPL variant (N291S) significantly influences the biochemical phenotype and risk for cardiovascular disease in patients with FH.
最近,脂蛋白脂肪酶(LPL)基因(N291S)的一种突变在西方人群2%至5%的个体中被报道,且与甘油三酯(TG)升高和高密度脂蛋白胆固醇(HDLC)浓度降低相关。
在此我们报告了携带这种N291S LPL突变的杂合子家族性高胆固醇血症(FH)患者在生化和临床表型上的显著改变。与175名未携带这种LPL突变的FH杂合子相比,64名携带N291S突变的FH杂合子的TG水平显著更高(P = 0.004),总胆固醇与HDLC的比率更高(P < 0.001),HDLC浓度更低(P = 0.002)。此外,与未携带这种LPL突变的FH杂合子相比,N291S突变使FH杂合子发生心血管疾病的风险显著更高(优势比,3.875;P = 0.006)。
这些数据提供了证据,表明一种常见的LPL变异(N291S)显著影响FH患者的生化表型和心血管疾病风险。